Zobrazeno 1 - 10
of 38
pro vyhledávání: '"C, Georganas"'
Autor:
Argyro Repa, Dimitrios Vassilopoulos, C. Georganas, Alexandros Garyfallos, M. Areti, Pelagia Katsimbri, Theodoros Dimitroulas, Evripidis Kaltsonoudis, Lazaros I. Sakkas, Alexandros A. Drosos, Argyriou Evangelia, Konstantinos Melissaropoulos, P. Vounotrypidis, Georgios Georgiopoulos, Gerasimos Evangelatos, S. Gazi, Dimitrios T. Boumpas, Eleftheria P. Grika, Prodromos Sidiropoulos, P. G. Vlachoyiannopoulos, Konstantina Karagianni, Kalliopi Fragkiadaki, P. Tsatsani, Maria G Tektonidou, Panagiotis Georgiou, Kyriaki A. Boki, Petros P. Sfikakis, Alexios Iliopoulos, Argyro Lazarini, Paraskevi V. Voulgari, Ainour Molla Ismail Sali, George D. Kitas, Konstantinos Thomas
Publikováno v:
Rheumatology. 60:2223-2230
Objectives Predicting serious infections (SI) in patients with rheumatoid arthritis (RA) is crucial for the implementation of appropriate preventive measures. Here we aimed to identify risk factors for SI and to validate the RA Observation of Biologi
Autor:
Panagiotis Georgiou, Kyriaki A. Boki, Petros P. Sfikakis, Ioannis Papalopoulos, L. Pantazi, Theodoros Dimitroulas, Maria G Tektonidou, P. G. Vlachoyiannopoulos, Argiro Lazarini, P. Tsatsani, Prodromos Sidiropoulos, Konstantina Karagianni, Konstantinos Melissaropoulos, C. Georganas, Alexandros A. Drosos, Gerasimos Evangelatos, Alexandros Garyfallos, Alexios Iliopoulos, M. Areti, Lazaros I. Sakkas, Kalliopi Fragkiadaki, Dimitrios Vassilopoulos, Pelagia Katsimbri, Dimitrios T. Boumpas, Evripidis Kaltsonoudis, S. Gazi, P. Vounotrypidis, Eleftheria P. Grika, George D. Kitas, Konstantinos Thomas
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 12 (2020)
Therapeutic Advances in Musculoskeletal Disease
Therapeutic Advances in Musculoskeletal Disease
Background: Data regarding the real-life predictors of low disease activity (LDA) in rheumatoid arthritis (RA) patients are limited. Our aim was to evaluate the rate and predictors of LDA and treatment patterns in RA. Methods: This was a multicenter,
Autor:
L. Pantazi, P. G. Vlachoyiannopoulos, Evripidis Kaltsonoudis, S. Gazi, Konstantinos Melissaropoulos, Gerasimos Evangelatos, Argiro Lazarini, Panagiotis Georgiou, Kyriaki A. Boki, Ioannis Papalopoulos, Maria G Tektonidou, Eleftheria P. Grika, Alexandros A. Drosos, Dimitrios G. Kassimos, P. Tsatsani, Kalliopi Fragkiadaki, Petros P. Sfikakis, Clio P. Mavragani, Christos Mavrommatis, Dimitrios Vassilopoulos, Dimitrios T. Boumpas, Ilias Bournazos, M. Areti, Konstantina Karagianni, Pelagia Katsimbri, Lazaros I. Sakkas, P. Vounotrypidis, Alexios Iliopoulos, Prodromos Sidiropoulos, C. Georganas, Alexandros Garyfallos, Theodoros Dimitroulas, Gikas Katsifis, Konstantinos Ntelis, George D. Kitas, Konstantinos Thomas
Publikováno v:
Mediterranean Journal of Rheumatology, Vol 29, Iss 1, Pp 27-37 (2018)
Mediterranean Journal of Rheumatology
Mediterranean Journal of Rheumatology
Aim of the study To evaluate the current disease characteristics, treatment and comorbidities of rheumatoid arthritis (RA) in Greece. Methods Multicenter, cross-sectional study with a 9-month recruitment period between 2015 and 2016. Demographics, di
Autor:
Maria G Tektonidou, P. Vounotrypidis, Kalliopi Fragkiadaki, P. Tsatsani, Evripidis Kaltsonoudis, L. Pantazi, Konstantinos Melissaropoulos, Pelagia Katsimbri, Eleftheria P. Grika, S. Gazi, Gerasimos Evangelatos, Argyro Lazarini, Georgios Georgiopoulos, Prodromos Sidiropoulos, George D. Kitas, Panayiotis G. Vlachoyiannopoulos, Panagiotis Georgiou, Ioannis Papalopoulos, Theodoros Dimitroulas, Konstantinos Thomas, Alexios Iliopoulos, Kyriaki A. Boki, M. Areti, Alexandros A. Drosos, Konstantina Karagianni, C. Georganas, Alexandros Garyfallos, Lazaros I. Sakkas, Petros P. Sfikakis, Dimitrios T. Boumpas, Dimitrios Vassilopoulos
Publikováno v:
Oral Presentations.
Background Identification of the risk factors for the development of serious infections in patients with rheumatoid arthritis (RA) is critical for designing preventive measures and early treatment. Objectives To identify risk factors for serious infe
Autor:
George D. Kitas, Konstantinos Thomas, Lazaros I. Sakkas, Prodromos Sidiropoulos, Konstantinos Melissaropoulos, C. Georganas, Alexandros Garyfallos, P.P. Sfikakis, Konstantina Karagianni, Maria G Tektonidou, P.G. Vlachoyiannopoulos, Panagiotis Georgiou, Argyro Lazarini, Gerasimos Evangelatos, Kyriaki A. Boki, Dimitrios T. Boumpas, M. Areti, Alexandros A. Drosos, K. Ntelis, Argyro Repa, Pelagia Katsimbri, Dimitrios Vassilopoulos, Eleftheria P. Grika, Theodoros Dimitroulas, Evangelia Argyriou, P. Tsatsani, Evripidis Kaltsonoudis, S. Gazi, Kalliopi Fragkiadaki, Alexios Iliopoulos, P. Vounotrypidis
Publikováno v:
Annals of the Rheumatic Diseases. 79:1892.3-1892
Background:Despite the increased incidence of influenza infection in rheumatoid arthritis (RA) patients, vaccination coverage has been shown to be suboptimal. Prospective data regarding the current rate and predictors of influenza vaccination adheren
Autor:
P.P. Sfikakis, Pelagia Katsimbri, Konstantina Karagianni, Maria G Tektonidou, Alexandros A. Drosos, P. Vounotrypidis, L. Pantazi, Kalliopi Fragkiadaki, C. Georganas, Alexandros Garyfallos, Alexios Iliopoulos, Lazaros I. Sakkas, Dimitrios Vassilopoulos, P.G. Vlachoyiannopoulos, P. Tsatsani, Eleftheria P. Grika, Dimitrios T. Boumpas, Argyro Lazarini, Evripidis Kaltsonoudis, S. Gazi, Theodoros Dimitroulas, M. Areti, George D. Kitas, Konstantinos Thomas, Panagiotis Georgiou, Kyriaki A. Boki, Konstantinos Melissaropoulos, Gerasimos Evangelatos
Publikováno v:
Rheumatoid arthritis – biological DMARDs.
Background A number of cross-sectional studies have shown that approximately one quarter of rheumatoid arthritis (RA) patients are being treated with biologic disease modifying anti-rheumatic drugs (bDMARDs) as monotherapy. Data regarding the retenti
Autor:
Theodoros Dimitroulas, M. Areti, Maria G Tektonidou, Konstantinos Melissaropoulos, Alexios Iliopoulos, P.P. Sfikakis, P.G. Vlachoyiannopoulos, P. Vounotrypidis, Gerasimos Evangelatos, Evripidis Kaltsonoudis, Kalliopi Fragkiadaki, Konstantina Karagianni, Panagiotis Georgiou, Kyriaki A. Boki, Alexandros A. Drosos, Lazaros I. Sakkas, S. Gazi, Eleftheria P. Grika, C. Georganas, Alexandros Garyfallos, Pelagia Katsimbri, P. Tsatsani, Dimitrios T. Boumpas, Argyro Lazarini, Dimitrios Vassilopoulos, L. Pantazi, George D. Kitas, Konstantinos Thomas
Publikováno v:
THURSDAY, 14 JUNE 2018.
Background It is unclear if the widespread use of biologic DMARDs (bDMARDs) and the implementation of the treat to target approach have led to better disease control in patients with rheumatoid arthritis (RA) in daily clinical practice. Objectives To
Autor:
L. Pantazi, Gerasimos Evangelatos, Dimitrios Vassilopoulos, P. Vounotrypidis, C Mavromatis, Panagiotis Georgiou, Kyriaki A. Boki, C. Georganas, P. Tsatsani, Dimitrios T. Boumpas, Alexandros Garyfallos, K Delis, M. Areti, Prodromos Sidiropoulos, Alexandros A. Drosos, Gikas Katsifis, D Kasimos, George D. Kitas, Eleftheria P. Grika, Ioannis Papalopoulos, P.P. Sfikakis, Konstantinos Thomas, Lazaros I. Sakkas, P.G. Vlachoyiannopoulos, Pelagia Katsimbri, Theodoros Dimitroulas, Kalliopi Fragiadaki, K. Mavragani, I. Bournazos, Alexios Iliopoulos, Maria G Tektonidou, Evripidis Kaltsonoudis, S. Gazi, K Karagianni
Publikováno v:
Poster Presentations.
Background There are limited literature data regarding the characteristics of rheumatoid arthritis (RA) patients treated with biologic DMARD (bDMARD) monotherapy. Objectives To evaluate the disease and treatment characteristics of RA patients treated
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D. Ioakimidis, T. Kontomerkos, C. Iatrou, B. Vidalaki, P. Athanassiou, C. Georganas, K. Iliadou
Publikováno v:
Clinical Rheumatology. 15:189-192
We describe the case of a 32-year-old splenectomised man with severe Wegener's granulomatosis which was refractory to conventional treatment with oral cyclophosphamide and prednisolone. Remission was temporarily induced only with plasma exchange or i